ImClone studying Bristol-Myers Squibb’s offer
SAN FRANCISCO (MarketWatch) — ImClone Systems Inc. late Thursday confirmed it received an offer from Bristol-Myers Squibb . However, other than stating that it is studying the “situation,” the company did not offer any other comments. Bristol-Myers Squibb has offered to buy the shares of ImClone that it does not already own for $60 a share or a total of $4.5 billion. Bristol-Myers has owned about 17% of ImClone since September 2001. Carl Icahn, the billionaire investor activist, is chairman of ImClone.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
More @ DollarDrops.com:MBIA Cuts Bonus Payments To Executives >MBI
MBIA cuts executive bonuses, ups salaries
MBIA Expects Loss Payments Of $700M-$800M For 2008 >MBI
MBIA sells municipal bonds to raise cash: report
Davis Selected Advisers reports 5.1% stake in MBIA Inc.
Original post by Forextvblog
![[Most Real time JPY/USD Dollar Exchange Rate YEN/DOLLAR]](http://www.weblinks247.com/exrate/24hr-jpy-small.gif)
![[Most Real time EUR/USD Dollar Exchange Rate EURO/DOLLAR]](http://www.weblinks247.com/exrate/24hr-euro-small.gif)
![[Most Real Indian Rupee USD Dollar Exchange Rate ]](http://www.weblinks247.com/exrate/24hr-inr-small.gif)
![[Most Real USD Canadian Dollar Exchange Rate]](http://www.weblinks247.com/exrate/24hr-cad-small.gif)
![[Most Real Time British Pound to USD Dollar Exchange Rate ]](http://www.weblinks247.com/exrate/24hr-gbp-small.gif)
![[Most Real Time Swiss Franc to US Dollar Exchange Rate]](http://www.weblinks247.com/exrate/24hr-chf-small.gif)